Literature DB >> 16500123

Human umbilical cord blood-derived stromal cell, a new resource of feeder layer to expand human umbilical cord blood CD34+ cells in vitro.

Lei Gao1, Xinghua Chen, Xi Zhang, Yao Liu, Peiyan Kong, Xiangui Peng, Lin Liu, Hong Liu, Dongfeng Zeng.   

Abstract

Allogeneic transplantation with human umbilical cord blood (hUCB) in adult recipients is mainly limited by a low CD34+ cell dose. To break the limit, hUCB as a novel source of hUCB-derived stromal cells was incorporated in an attempt to expand CD34+ cells from hUCB in vitro. Cord blood CD34 cells were separated by MACS system. HUCB-derived stromal cells were cultured by the Dexter system and characterized by morphologic, immunophenotypical, and functional analysis. We studied the effects of hUCB-derived stromal cells, cytokines, and hUCB-derived stromal cells combined with cytokines on expansion of hUCB CD34 cells. The CD34+ cells were assessed for the degree of expansion and the number of colony-forming units in semisolid culture. Our research found that hUCB-derived stromal cells were mainly composed of three kinds of cell components, with CD106, CD29, CD44, CD45, CD50, CD68, CD31, Fn, Lm, and collagen IV positive, but CD34 negative immunophenotype. Functionally, it was discovered by cell cycle and growth curve analyses that the capability of colony and parietal layer formation of hUCB-derived stromal cells was poorer than that of BM stromal cells, and the doubling time of hUCB-derived stromal cells was longer than that of BM stromal cells. It was indicated by ELISA and RT-PCR that hUCB-derived stromal cells express higher level of TPO and less GM-CSF and SCF than BM stromal cell. Adherent layer of hUCB-derived stromal cells alone or combining with cytokines, increased CD34+ cell expansion. In vitro formation of CFUs by expanded CCD34 cells was significantly higher than that of unexpanded CD34+ cells (P < 0.05). When cocultured with hUCB-derived stromal cells in the presence of cytokines, cell growth was significantly enhanced: CD34 cells by 8.02 +/- 0.96-fold, CFU-GM by 217.60 +/- 6.72-fold, CFU-E by 1940.80 +/- 52.78-fold, and CFU-Mg by 142.60 +/- 4.39-fold. HUCB-derived stromal cells have significant superiority on the expansion of CFU-Mg (P < 0.05). The results indicate that human umbilical cord blood-derived stromal cells may be a suitable feeder layer for expansion of hematopoietic progenitors from hUCB in vitro.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16500123     DOI: 10.1016/j.bcmd.2005.12.036

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  15 in total

Review 1.  Mesenchymal stromal cells for cell therapy: besides supporting hematopoiesis.

Authors:  Lei Hao; Huiqin Sun; Jin Wang; Tao Wang; Mingke Wang; Zhongmin Zou
Journal:  Int J Hematol       Date:  2011-12-20       Impact factor: 2.490

Review 2.  Umbilical cord-derived mesenchymal stem cells: strategies, challenges, and potential for cutaneous regeneration.

Authors:  Siming Yang; Sha Huang; Changjiang Feng; Xiaobing Fu
Journal:  Front Med       Date:  2012-03-31       Impact factor: 4.592

3.  Trophic factor induction of human umbilical cord blood cells in vitro and in vivo.

Authors:  Ning Chen; Siddharth Kamath; Jennifer Newcomb; Jennifer Hudson; Svitlana Garbuzova-Davis; Paula Bickford; Cyndy Davis-Sanberg; Paul Sanberg; Tanja Zigova; Alison Willing
Journal:  J Neural Eng       Date:  2007-04-04       Impact factor: 5.379

4.  Comparison of TGFbR2 down-regulation in expanded HSCs on MBA/DBM scaffolds coated by UCB stromal cells.

Authors:  Zahra Sadat Hashemi; Mehdi Forouzandeh Moghadam; Masoud Soleimani
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-12-25       Impact factor: 2.416

5.  Human umbilical cord blood-derived stromal cells, a new resource in the suppression of acute graft-versus-host disease in haploidentical stem cell transplantation in sublethally irradiated mice.

Authors:  Cheng Zhang; Xing-Hua Chen; Xi Zhang; Lei Gao; Pei-Yan Kong; Xian-gui Peng; Xue Liang; Li Gao; Yi Gong; Qing-Yu Wang
Journal:  J Biol Chem       Date:  2011-02-24       Impact factor: 5.157

6.  Human umbilical cord blood-derived stromal cells are superior to human umbilical cord blood-derived mesenchymal stem cells in inducing myeloid lineage differentiation in vitro.

Authors:  Hao-Ping Sun; Xi Zhang; Xing-Hua Chen; Cheng Zhang; Lei Gao; Yi-Mei Feng; Xian-Gui Peng; Li Gao
Journal:  Stem Cells Dev       Date:  2011-12-05       Impact factor: 3.272

7.  Ginsenoside Rg1 protects human umbilical cord blood-derived stromal cells against tert-Butyl hydroperoxide-induced apoptosis through Akt-FoxO3a-Bim signaling pathway.

Authors:  Ying Liu; Long Yi; Lu Wang; Linbo Chen; Xiongbin Chen; Yaping Wang
Journal:  Mol Cell Biochem       Date:  2016-08-13       Impact factor: 3.396

Review 8.  Wharton's jelly-derived cells are a primitive stromal cell population.

Authors:  Deryl L Troyer; Mark L Weiss
Journal:  Stem Cells       Date:  2007-12-06       Impact factor: 6.277

9.  Effect of testosterone and hypoxia on the expansion of umbilical cord blood CD34+ cells in vitro.

Authors:  Liping Zhou; Xiaowei Zhang; Panpan Zhou; Xue Li; Xuejing Xu; Qing Shi; Dong Li; Xiuli Ju
Journal:  Exp Ther Med       Date:  2017-08-24       Impact factor: 2.447

10.  Human umbilical cord blood-derived stromal cells suppress xenogeneic immune cell response in vitro.

Authors:  Lei Hao; Cheng Zhang; Xing-Hua Chen; Zhong-Min Zou; Xi Zhang; Pei-Yan Kong; Xue Liang; Lei Gao; Xian-Gui Peng; Ai-Hua Sun; Qing-Yu Wang
Journal:  Croat Med J       Date:  2009-08       Impact factor: 1.351

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.